Serendipity Impact VC

Welcome to the fourth issue of Mental Health Tech Insider —your compass for navigating the intersection of technology and mental health. Whether you’re an investor, entrepreneur, advisor, or simply fascinated by the industry’s evolution, this newsletter is designed for you. This week, we dive into neuromodulation—the process of rewiring the brain to treat mental health issues (among others), examine investment trends in behavioral health, and explore why the U.S. Surgeon General is advocating for warning labels on social media platforms. In a world full of tech, stay human, see human, Maria Serendipity Impact VC #MentalHealthInnovation #MentalHealthtech #InvestingInFuture

Welcome to the third issue of Mental Health Tech Insider —your compass for navigating the intersection of technology and mental health. This week, we explore the first FDA-approved digital treatment for Major Depressive Disorder (MDD) and its potential impact on technology adoption in mental health and highlight new research showing promising results from XR-Enhanced Behavioral Activation for Depression. Plus, why we often have a higher trust in people in uniform—aka the authority bias. If you're in NYC on May 5th, come say hi at the https://lnkd.in/eBZtZ6iu event. Best, Maria Serendipity Impact VC #MentalHealthInnovation #MentalHealthtech #InvestingInFuture